135 related articles for article (PubMed ID: 16110803)
21. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
Musher B; Fredricks D; Leisenring W; Balajee SA; Smith C; Marr KA
J Clin Microbiol; 2004 Dec; 42(12):5517-22. PubMed ID: 15583275
[TBL] [Abstract][Full Text] [Related]
22. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
Armenian SH; Nash KA; Kapoor N; Franklin JL; Gaynon PS; Ross LA; Hoffman JA
J Pediatr Hematol Oncol; 2009 Dec; 31(12):920-6. PubMed ID: 19855303
[TBL] [Abstract][Full Text] [Related]
23. Aspergillus polymerase chain reaction (PCR) diagnosis.
Buchheidt D; Hummel M
Med Mycol; 2005 May; 43 Suppl 1():S139-45. PubMed ID: 16110806
[TBL] [Abstract][Full Text] [Related]
24. Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients.
Einsele H; Loeffler J
Clin Microbiol Infect; 2008 May; 14 Suppl 4():37-45. PubMed ID: 18430128
[TBL] [Abstract][Full Text] [Related]
25. Potential of polymerase chain reaction and galactomannan for the diagnosis of invasive aspergillosis in patients with febrile neutropenia.
Aslan M; Oz Y; Aksit F; Akay OM
Mycoses; 2015 Jun; 58(6):343-9. PubMed ID: 25851634
[TBL] [Abstract][Full Text] [Related]
26. Molecular diagnosis of invasive aspergillosis: the long and winding road.
Boudewijns M; Verweij PE; Melchers WJ
Future Microbiol; 2006 Oct; 1(3):283-93. PubMed ID: 17661641
[TBL] [Abstract][Full Text] [Related]
27. Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples.
Danylo A; Courtemanche C; Pelletier R; Boudreault AA
Med Mycol; 2014 Aug; 52(6):577-83. PubMed ID: 25023484
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients.
El-Mahallawy HA; Shaker HH; Ali Helmy H; Mostafa T; Razak Abo-Sedah A
Med Mycol; 2006 Dec; 44(8):733-9. PubMed ID: 17127630
[TBL] [Abstract][Full Text] [Related]
29. Cerebral aspergillosis diagnosed by detection of Aspergillus flavus-specific DNA, galactomannan and (1-->3)-beta-D-glucan in clinical specimens.
Khan ZU; Ahmad S; Mokaddas E; Said T; Nair MP; Halim MA; Nampoory MR; McGinnis MR
J Med Microbiol; 2007 Jan; 56(Pt 1):129-132. PubMed ID: 17172527
[TBL] [Abstract][Full Text] [Related]
30. Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children.
Huppler AR; Fisher BT; Lehrnbecher T; Walsh TJ; Steinbach WJ
J Pediatric Infect Dis Soc; 2017 Sep; 6(suppl_1):S32-S44. PubMed ID: 28927202
[TBL] [Abstract][Full Text] [Related]
31. Role of Non-Culture-Based Tests, with an Emphasis on Galactomannan Testing for the Diagnosis of Invasive Aspergillosis.
Miceli MH; Maertens J
Semin Respir Crit Care Med; 2015 Oct; 36(5):650-61. PubMed ID: 26398532
[TBL] [Abstract][Full Text] [Related]
32. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial.
Morrissey CO; Chen SC; Sorrell TC; Milliken S; Bardy PG; Bradstock KF; Szer J; Halliday CL; Gilroy NM; Moore J; Schwarer AP; Guy S; Bajel A; Tramontana AR; Spelman T; Slavin MA;
Lancet Infect Dis; 2013 Jun; 13(6):519-28. PubMed ID: 23639612
[TBL] [Abstract][Full Text] [Related]
33. [Laboratory diagnosis of invasive aspergillosis].
del Palacio A; Cuétara MS; Pontón J
Rev Iberoam Micol; 2003 Sep; 20(3):90-8. PubMed ID: 15456364
[TBL] [Abstract][Full Text] [Related]
34. Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens.
Schabereiter-Gurtner C; Selitsch B; Rotter ML; Hirschl AM; Willinger B
J Clin Microbiol; 2007 Mar; 45(3):906-14. PubMed ID: 17251398
[TBL] [Abstract][Full Text] [Related]
35. Advances in molecular detection of Aspergillus: an update.
Abdin MZ; Ahmad MM; Javed S
Arch Microbiol; 2010 Jun; 192(6):409-25. PubMed ID: 20358179
[TBL] [Abstract][Full Text] [Related]
36. Development of a nested qualitative real-time PCR assay to detect Aspergillus species DNA in clinical specimens.
Halliday C; Wu QX; James G; Sorrell T
J Clin Microbiol; 2005 Oct; 43(10):5366-8. PubMed ID: 16208020
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of aspergillosis by PCR: Clinical considerations and technical tips.
Barnes RA; White PL; Morton CO; Rogers TR; Cruciani M; Loeffler J; Donnelly JP
Med Mycol; 2018 Apr; 56(suppl_1):60-72. PubMed ID: 29087518
[TBL] [Abstract][Full Text] [Related]
38. Identification of pathogenic Aspergillus species by a PCR-restriction enzyme method.
Mirhendi H; Diba K; Kordbacheh P; Jalalizand N; Makimura K
J Med Microbiol; 2007 Nov; 56(Pt 11):1568-1570. PubMed ID: 17965363
[No Abstract] [Full Text] [Related]
39. Invasive fungal infections: biomarkers and molecular approaches to diagnosis.
Schuetz AN
Clin Lab Med; 2013 Sep; 33(3):505-25. PubMed ID: 23931836
[TBL] [Abstract][Full Text] [Related]
40. Galactomannan and polymerase chain reaction for the diagnosis of primary digestive aspergillosis in a patient with acute myeloid leukaemia.
Chambon-Pautas C; Costa JM; Chaumette MT; Cordonnier C; Bretagne S
J Infect; 2001 Oct; 43(3):213-4. PubMed ID: 11798263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
